Cipla Stocks News Today

Cipla Ltd. key Products/Revenue Segments include Pharmaceuticals, Royalty Income, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Mar-2023.

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 106223.84 Crore) operating in Pharmaceuticals sector.

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 102978.40 Crore) operating in Pharmaceuticals sector.

Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 96996.11 Crore) operating in Pharmaceuticals sector.

Company says there’s no significant risk to its existing commercial product portfolio

Cipla recorded an 8% growth in sales on the back of the launch of the generic version of Revlimid and gained market share in lanreotide, albuterol and arformoterol drug sales. While some regulatory issues have entangled the company, it is focusing on resolving the same at its key manufacturing units in Goa and Pithampur, while also filing critical products such as generics of Abraxane, Advair from alternate sites and de-risking the opportunity.

The brokerage values CIPLA at 25x 12Mforward earnings and add NPV of INR30 related to g-Revlimid to arrive at its TPof INR1,420.

In this insightful article, we delve into the concept of the overbought zone and its relevance in the stock market. We explore the Relative Strength Index (RSI) and its significance in assessing stock movements. On August 4, Friday, over 70 stocks were trading in an overbought zone, and ETMarkets has cherry-picked ten of these stocks for closer examination. Aspiring investors can gain valuable insights from the analysis of these stocks to make informed decisions.

Blackstones bid to acquire the promoter stake in Cipla, Indias third-largest drug company, highlights the fact that an integral part of Indias industrial history is set to fade into museums. Cipla has been closely associated with Indias struggle for independence, with Khwaja Abdul Hamied forming the company in 1935, chartered by Indias most influential independence fighters, including Mahatma Gandhi and Subhash Chandra Bose.

Price sustaining above recent breakout area signaling further upward momentum